REGENXBIO Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
REGENXBIO Inc. (RGNX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $26.00 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Notes
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2017-08-08
- 2017-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $26.00M.
- 2017-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $26.20M.
- 2016-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $18.40M.
- 2016-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $19.00M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2017-06-30 | $26.00M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $26.20M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $18.40M 10-K · filed 2017-03-07 |
| 2016-09-30 | $19.00M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $19.04M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $19.17M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $11.13M 10-K · filed 2016-03-03 |
| 2015-09-30 | $5.00M 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |